Englewood Lab Inc (950140) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Englewood Lab Inc (950140) has a cash flow conversion efficiency ratio of 0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.76 Billion ≈ $4.58 Million USD) by net assets (₩154.89 Billion ≈ $104.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Englewood Lab Inc to measure how much of total assets are equity-financed.
Englewood Lab Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Englewood Lab Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Englewood Lab Inc to evaluate the quality of earnings relative to operating cash generation.
Englewood Lab Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Englewood Lab Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nahar Spinning Mills Limited
NSE:NAHARSPING
|
0.219x |
|
SINGULAR PEOPLE S EO-1
F:H0U
|
N/A |
|
China National Accord Medicines Corp Ltd
SHE:200028
|
-0.019x |
|
ALEXANDRIA PANKKIIRILIIKE
F:3ZL
|
N/A |
|
CEA Industries Inc.
NASDAQ:BNC
|
0.018x |
|
Austral Resources Australia Ltd
AU:AR1
|
-0.593x |
|
Taseco Air Services JSC
VN:AST
|
0.091x |
|
Kervansaray Yatirim Holding AS
IS:KERVN
|
0.067x |
Annual Cash Flow Conversion Efficiency for Englewood Lab Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of Englewood Lab Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Englewood Lab Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩97.89 Million ≈ $66.34K |
₩9.47 Million ≈ $6.42K |
0.097x | -46.14% |
| 2023-12-31 | ₩89.12 Million ≈ $60.40K |
₩16.01 Million ≈ $10.85K |
0.180x | -99.86% |
| 2022-12-31 | ₩73.41 Million ≈ $49.75K |
₩9.56 Billion ≈ $6.48 Million |
130.256x | +229.58% |
| 2021-12-31 | ₩68.28 Million ≈ $46.28K |
₩-6.86 Billion ≈ $-4.65 Million |
-100.526x | -176.80% |
| 2020-12-31 | ₩55.76 Million ≈ $37.79K |
₩7.30 Billion ≈ $4.95 Million |
130.892x | -42.97% |
| 2019-12-31 | ₩52.79 Million ≈ $35.78K |
₩12.12 Billion ≈ $8.21 Million |
229.494x | +224.24% |
| 2018-12-31 | ₩50.72 Million ≈ $34.37K |
₩-9.37 Billion ≈ $-6.35 Million |
-184.721x | -15.82% |
| 2017-12-31 | ₩56.31 Million ≈ $38.16K |
₩-8.98 Billion ≈ $-6.09 Million |
-159.487x | -340171.13% |
| 2016-12-31 | ₩61.90 Million ≈ $41.95K |
₩-2.90 Million ≈ $-1.97K |
-0.047x | -10.74% |
| 2015-12-31 | ₩26.65 Billion ≈ $18.06 Million |
₩-1.13 Billion ≈ $-764.48K |
-0.042x | -- |
About Englewood Lab Inc
Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; a… Read more